Final results from PAVES, a phase 3, randomized, double-blind, placebo-controlled trial of pegfilgrastim in patients (pts) receiving first-line FOLFOX or FOLFIRI and bevacizumab for locally advanced or metastatic colorectal cancer (LA/mCRC) (NCT00911170)

Please use this identifier to cite or link to this item: https://dspace.uzhnu.edu.ua/jspui/handle/lib/10601

Title:	Final results from PAVES, a phase 3, randomized, double-blind, placebo-controlled trial of pegfilgrastim in patients (pts) receiving first-line FOLFOX or FOLFIRI and bevacizumab for locally advanced or metastatic colorectal cancer (LA/mCRC) (NCT00911170)
Authors:	Готько, Євген Степанович T. Pinter P.K. Morrow A. Cesas A. Croitoru J. Decaestecker P. Gibbs J. Jassem G. Kurteva J. Novotny S. O'Reilly T. Salek L. Khosrowshahi M. Reiner Z. Klippel C. Blanke
Issue Date:	2015
Publisher:	Gastroentérologie Clinique et Biologique Vol 33, N° HS1 - mars 2009 p. 139
Type:	Text
Publication type:	Стаття
URI:	https://dspace.uzhnu.edu.ua/jspui/handle/lib/10601
Appears in Collections:	Наукові публікації кафедри радіології та онкології

Files in This Item:

File	Description	Size	Format
main.pdf.png		214.81 kB	image/png	View/Open